JMKX003002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JMKX003002, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia [Phase 2]